The concanavalin A model of acute hepatitis in mice

Laboratory Animals - Tập 49 Số 1_suppl - Trang 12-20 - 2015
Felix Heymann1, Karim Hamesch1, Ralf Weiskirchen2, Frank Tacke1
1Department of Internal Medicine III, RWTH University Hospital Aachen, Aachen, Germany
2Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry, RWTH University Hospital Aachen, Aachen, Germany for the Transregional Collaborative Research Center ‘Organ Fibrosis: From Mechanisms of Injury to Modulation of Disease’ (SFB/TRR57)

Tóm tắt

The intravenous injection of the plant lectin concanavalin A (ConA) is a widely used model for acute immune-mediated hepatitis in mice. In contrast to several other models for acute hepatic damage, ConA-induced injury is primarily driven by the activation and recruitment of T cells to the liver. Hence, the ConA model has unique features with respect to its pathogenesis and important similarities to immune-mediated hepatitis in humans, such as autoimmune hepatitis, acute viral hepatitis or distinct entities of drug toxicity leading to immune activation. However, the ConA model has considerable variability, depending on the preparation of the compound, genetic background of the mice, sex, age and microbial environment of the animal facility barrier. This standard operating procedure (SOP) comprises a detailed protocol for the ConA application, including preparation of ConA working solution, handling of the animals, choice of the appropriate conditions and endpoints, as well as efficient dose-finding.

Từ khóa


Tài liệu tham khảo

10.1016/j.addr.2003.10.030

Asherson GL, 1973, Clin Exp Immunol, 15, 573

10.1146/annurev.bi.55.070186.000343

10.1016/0006-291X(83)90996-8

10.1016/S0021-9258(18)86371-2

10.1128/JB.32.2.227-237.1936

10.1172/JCI115836

10.1016/0016-5085(94)90604-1

10.1016/0006-2952(90)90398-5

10.1016/0006-2952(89)90208-6

10.1016/j.taap.2012.08.015

10.1136/gutjnl-2011-300304

10.1002/hep.22950

10.1002/hep.24764

10.1016/j.bpg.2011.10.006

10.1084/jem.179.5.1529

10.1152/ajpgi.00105.2005

10.1016/S0168-8278(96)80301-1

10.1053/gast.1996.v111.pm8690213

Leist M, 1995, Am J Pathol, 146, 1220

10.1016/S0016-5085(98)70324-5

10.1093/emboj/17.6.1675

10.1084/jem.20082152

10.1038/35104568

10.1053/j.gastro.2014.07.018

10.1038/364806a0

10.1002/hep.25893

10.1038/cdd.2012.90

10.1053/j.gastro.2005.06.006

10.1002/hep.510240338

10.1016/S0168-8278(99)80284-0

10.1016/j.bbadis.2011.06.005

Gantner F, 1995, Hepatology, 21, 190

10.1002/hep.510240413

10.4049/jimmunol.169.12.7087

Massaguer A, 2002, J Leukoc Biol, 72, 262, 10.1189/jlb.72.2.262

10.1002/hep.21498

10.1016/S1386-6346(03)00263-8

10.1056/NEJMra1208937

10.1172/JCI504

10.1172/JCI10613

10.4049/jimmunol.1003750

10.1002/hep.21674

10.1002/hep.25542

10.1111/j.1365-2249.2011.04458.x

Hammerich L, Warzecha KT, Stefkova M, et al. CREMα overexpression impairs function of hepatic myeloid derived suppressor cells and aggravates immune-mediated hepatitis in mice. Hepatology 2015 (in press).

10.3758/BRM.41.4.1149

10.1016/S0021-9258(19)41843-7

10.1016/S0021-9258(19)41842-5

10.1016/S0076-6879(97)77027-7

Wang Y, Feng D, Wang H, et al. STAT4 knockout mice are more susceptible to concanavalin A-induced T-cell hepatitis. Am J Pathol 2014; 6: 184: 1785–1794.

Burghardt S, Erhardt A, Claass B, et al. Hepatocytes contribute to immune regulation in the liver by activation of the Notch signaling pathway in T cells. J Immunol 2013; 11: 191: 5574–5582.

Streetz K, Fregien B, Plümpe J, et al. Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failure. J Immunol 2001; 1: 167: 514–523.